Facebook
Twitter
Telegram
Report an ErrorTeva Pharmaceutical Industries Limited Financial Ratios 2011-2024 | TEVA
Annual Financial Ratios Teva Pharmaceutical Industries Limited
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-26.0 | -8.8 | 22.3 | -3.2 | -11.2 | -9.5 | -1.3 | 96.9 | 31.1 | 14.6 | 27.3 | 14.4 | 12.3 |
P/S |
0.9 | 0.8 | 0.6 | 0.8 | 0.7 | 1.1 | 0.9 | 1.5 | 2.5 | 2.2 | 1.7 | 1.4 | 1.8 |
EPS |
-0.5 | -1.2 | 0.4 | -3.6 | -0.9 | -2.4 | -16.3 | 0.1 | 1.8 | 3.6 | 1.5 | 2.2 | 3.1 |
EV (Enterprise Value) |
46.6 B | 44 B | 43.5 B | 50.3 B | 52.7 B | 64.6 B | 71.9 B | 88.8 B | 66.8 B | 65.4 B | 58.5 B | 53.1 B | 60.5 B |
EBITDA per Share |
1.42 | 0.33 | 2.76 | -1.84 | 1.17 | 0.201 | 6.01 | 6.47 | 7.51 | 7.03 | 6.6 | 6.75 | 5.71 |
EV/EBITDA |
14.1 | 7.9 | 9.4 | 232.0 | 8.0 | 10.3 | 7.9 | 8.5 | 7.9 | 6.3 | 8.5 | ||
PEG |
-0.59 | 0.21 | -0.88 | -0.15 | -0.2 | -0.11 | 0.0 | -1.01 | -0.64 | 0.1 | -0.81 | -0.52 | -0.74 |
P/B |
1.8 | 1.3 | 0.8 | 1.2 | 0.8 | 1.4 | 1.1 | 0.9 | 1.7 | 1.9 | 1.5 | 1.2 | 1.5 |
P/CF |
10.6 | 7.2 | 11.6 | 10.6 | 50.2 | 11.4 | 8.0 | 7.4 | 10.4 | 10.6 | 15.7 | 8.1 | 11.0 |
ROE % |
-7.45 | -16.67 | 3.71 | -36.07 | -7.15 | -14.62 | -86.77 | 0.94 | 5.31 | 13.08 | 5.61 | 8.58 | 12.35 |
ROA % |
-1.29 | -2.96 | 0.87 | -7.88 | -1.74 | -3.54 | -23.03 | 0.35 | 2.93 | 6.58 | 2.67 | 3.88 | 5.50 |
ROCE % |
1.41 | -2.96 | 4.68 | -9.53 | -1.01 | -3.53 | 7.57 | 6.26 | 12.40 | 13.16 | 11.14 | 11.08 | 11.05 |
Current Ratio |
1.2 | 1.2 | 1.3 | 1.3 | 1.0 | 1.0 | 0.9 | 0.9 | 1.4 | 1.2 | 1.1 | 1.3 | 1.0 |
DSO |
81.8 | 100.6 | 104.7 | 112.4 | 122.7 | 112.7 | 116.2 | 125.4 | 99.4 | 97.4 | 95.9 | 100.1 | 123.8 |
DIO |
174.8 | 175.6 | 181.1 | 180.3 | 172.6 | 163.6 | 155.5 | 180.0 | 174.5 | 173.1 | 192.0 | 207.8 | 208.0 |
DPO |
99.9 | 82.0 | 75.8 | 35.9 | 67.1 | 64.1 | 65.3 | 78.4 | - | - | - | - | - |
Operating Cycle |
256.6 | 276.2 | 285.8 | 292.7 | 295.3 | 276.3 | 271.7 | 305.4 | 273.9 | 270.5 | 287.9 | 307.9 | 331.8 |
Cash Conversion Cycle |
156.7 | 194.2 | 210.0 | 256.8 | 228.2 | 212.2 | 206.4 | 227.0 | 273.9 | 270.5 | 287.9 | 307.9 | 331.8 |
All numbers in USD currency
Quarterly Financial Ratios Teva Pharmaceutical Industries Limited
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.07 | -0.77 | -0.18 | - | 0.05 | -0.21 | -0.86 | - | 0.26 | 0.19 | 0.07 | 0.14 | -3.97 | 0.13 | 0.06 | 0.1 | -0.29 | -0.63 | -0.1 | -2.85 | -0.27 | -0.24 | 1.04 | -11.41 | 0.52 | -5.94 | 0.57 | -1.02 | 0.35 | 0.21 | 0.62 | - | 0.12 | 0.64 | 0.52 | - | 1.02 | 0.88 | 0.88 | - | 0.84 | -0.53 | 0.74 | - | -0.09 | 0.99 | 0.98 | - | 1.03 | 0.65 | 0.85 |
EBITDA per Share |
0.57 | -0.31 | 0.27 | - | 0.67 | -0.53 | -0.35 | - | 1.48 | 0.68 | 0.74 | - | -2.9 | 0.87 | 0.54 | - | 1.12 | 0.23 | 0.53 | - | 1.45 | 0.95 | 2 | - | 1.93 | -4.6 | 1.35 | - | 0.78 | 0.39 | 1.61 | - | 1.19 | 0.78 | 1.27 | - | 1.3 | 1.09 | 1.62 | - | 0.95 | -0.69 | 1.47 | - | -0.07 | 1.16 | 1.64 | - | 1.17 | 0.67 | 1.26 |
ROE % |
-13.10 | -13.67 | -3.79 | -11.08 | -8.53 | -6.57 | -2.20 | 5.33 | 6.82 | -39.11 | -39.71 | -39.80 | -40.51 | 0.62 | -5.70 | -7.14 | -27.55 | -26.72 | -22.99 | -14.62 | -61.45 | -56.60 | -89.80 | -93.70 | -26.08 | -28.33 | 6.90 | 4.10 | 4.56 | 3.84 | 5.34 | 4.76 | 8.47 | 11.72 | 12.56 | 10.12 | 13.31 | 12.79 | 7.51 | 3.86 | 3.52 | -0.02 | 5.88 | 7.18 | 11.18 | 15.53 | 14.17 | 9.74 | 4.01 | 2.43 | 3.30 |
ROA % |
-2.16 | -2.22 | -2.25 | -3.93 | -3.32 | -0.81 | -0.39 | 1.19 | 1.48 | -7.71 | -7.86 | -7.88 | -7.98 | 0.06 | -1.42 | -1.74 | -6.68 | -6.48 | -5.57 | -3.54 | -15.12 | -13.94 | -22.10 | -23.03 | -6.28 | -6.71 | 2.19 | 2.01 | 2.22 | 2.02 | 2.65 | 2.23 | 4.11 | 5.78 | 6.31 | 5.07 | 6.55 | 6.16 | 3.61 | 1.84 | 1.69 | 0.04 | 2.76 | 3.31 | 5.53 | 7.91 | 7.57 | 5.59 | 2.22 | 1.43 | 1.94 |
ROCE % |
0.35 | 0.46 | -7.09 | -10.39 | -8.66 | -8.21 | 3.09 | 4.58 | -7.34 | -20.98 | -22.15 | -10.92 | -11.11 | 0.62 | -1.36 | -1.38 | -1.35 | -1.12 | 0.35 | 3.37 | 4.11 | 4.81 | -6.35 | -8.71 | -7.72 | -7.47 | 4.58 | 4.62 | 7.47 | 9.33 | 10.31 | 6.87 | 10.05 | 10.39 | 11.20 | 8.59 | 10.83 | 9.90 | 5.55 | 3.01 | 2.85 | 0.45 | 4.74 | 4.97 | 8.46 | 12.09 | 11.48 | 8.33 | 3.48 | 1.99 | 2.86 |
Current Ratio |
1.2 | 1.2 | 1.2 | 1.2 | 1.3 | - | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.6 | 2.2 | 2.2 | 2.2 | 1.9 | 1.9 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 1.9 | 1.9 | 1.8 | 1.9 | 1.8 | 1.9 | 1.9 | 1.9 | 1.8 | 2.2 | 2.5 | 2.4 |
DSO |
82.0 | 82.0 | 88.9 | - | 47.3 | 51.2 | 109.5 | - | 100.2 | 105.7 | 104.9 | 93.8 | 105.1 | 108.0 | 107.4 | 115.9 | 126.5 | 124.0 | 126.4 | 120.2 | 121.2 | 116.7 | 116.7 | 119.2 | 115.9 | 113.7 | 118.3 | 109.6 | 110.3 | 95.7 | 100.0 | - | 102.6 | 101.8 | 100.0 | - | 97.4 | 96.4 | 96.8 | - | 94.7 | 99.3 | 102.3 | - | 102.9 | 104.9 | 112.1 | - | 116.3 | 119.6 | - |
DIO |
186.2 | 180.3 | 174.5 | - | 91.4 | 91.9 | 186.0 | - | 185.9 | 196.4 | 191.0 | - | 189.0 | 190.7 | 175.5 | - | 178.2 | 176.7 | 182.1 | - | 169.2 | 161.8 | 160.2 | - | 151.4 | 156.8 | 160.3 | - | 153.1 | 166.4 | 179.2 | - | 184.9 | 185.7 | 181.7 | - | 193.3 | 189.8 | 198.6 | - | 198.5 | 209.7 | 214.9 | - | 206.9 | 207.4 | 189.3 | - | 198.5 | 196.9 | - |
DPO |
109.3 | 107.1 | 93.7 | - | 38.7 | 40.1 | 81.6 | - | 66.8 | 72.6 | 74.8 | - | 75.4 | 76.0 | 69.1 | - | 69.2 | 68.6 | 34.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
268.3 | 262.3 | 263.4 | - | 138.8 | 143.1 | 295.4 | - | 286.1 | 302.1 | 295.9 | 93.8 | 294.1 | 298.7 | 282.9 | 115.9 | 304.8 | 300.7 | 308.6 | 120.2 | 290.3 | 278.5 | 276.8 | 119.2 | 267.4 | 270.5 | 278.6 | 109.6 | 263.4 | 262.1 | 279.1 | - | 287.5 | 287.4 | 281.6 | - | 290.8 | 286.2 | 295.4 | - | 293.2 | 309.0 | 317.2 | - | 309.8 | 312.4 | 301.4 | - | 314.8 | 316.5 | - |
Cash Conversion Cycle |
159.0 | 155.2 | 169.7 | - | 100.0 | 103.1 | 213.8 | - | 219.3 | 229.5 | 221.1 | 93.8 | 218.7 | 222.7 | 213.8 | 115.9 | 235.5 | 232.0 | 274.4 | 120.2 | 290.3 | 278.5 | 276.8 | 119.2 | 267.4 | 270.5 | 278.6 | 109.6 | 263.4 | 262.1 | 279.1 | - | 287.5 | 287.4 | 281.6 | - | 290.8 | 286.2 | 295.4 | - | 293.2 | 309.0 | 317.2 | - | 309.8 | 312.4 | 301.4 | - | 314.8 | 316.5 | - |
All numbers in USD currency